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Multistep Process of Squamous
Differentiation in Tracheobronchial Epithelial
Cells In Vitro: Analogy with Epidermal
Differentiation
by Anton M. Jetten*
The lung, inparticularthe bronchial epithelium, is a majorsite fortumorformation in humans. Environ-
mental factors, such as cigarette smoke, in conjunction with genetic factors are important determinants in
this disease. Malignant cellsexhibit alterations in theircontrol ofproliferation and differentiation. It is be-
lieved that the acquisition ofdefects in the regulation ofthese processes is important in the process ofcar-
cinogenesis. Aclear insight into the basic mechanisms ofthe regulation ofproliferation and differentiation
is required to understand the molecularmechanisms involved in tumordevelopment and inotherpathological
conditions. Studies using in vitrocell culture systemsoftracheobronchial epithelial cellsprovide useful models
in which to study the regulation ofdifferentiation and proliferation. The clonogenic cells derived from the
treacheobronchial epithelium are pluripotent: They have self-renewal capacity and can differentiate along
either anormal, mucosecretory, orasquamous cell pathway. Squamous differentiation intracheobronchial
epithelial cells has many morphological, biochemical, and regulatory properties in common with epidermal
differentiation. This pathway ofdifferentiation is a multistep process consisting ofat least three stages. In
the initial stage, cells become committed to terminal cell division. This is followed by the expression ofthe
squamous differentiatedphenotype andfinally cornification. Various factors, such as several growth factors,
retinoids, calcium ions, andphorbol esters, regulate theprogram ofdifferentiation at different stages. Studies
have indicated that the controls ofproliferation and differentiation are interrelated. Cell lines established
from tracheobronchial epithelial cells expressing SV40 large T-antigen, as well as carcinoma cell lines, ex-
hibit altered responses to growth and differentiation regulatory factors Alterations in the commitment to
terminal cell division must be a crucial step in the transition ofa normal to a malignant cell.
Introduction
The tracheobronchial lining consists of apseudostrati-
fied epithelium(1,2), whichhasbeen shownultrastructur-
ally to contain a diverse population ofcell types, the ma-
jor ones beingciliated, basal, and secretory cells(mucous,
Clara, and/or serous cells, depending on species). In con-
trast to ciliated cells, which are considered to be termi-
nally differentiated cells, the basal, Clara, and mucous-
secreting cells have proliferative capacity (3-11). Next to
their secretory function, the Clara and mucous-secreting
cells are able to differentiate, probably via independent
pathways, into ciliated cells (6,8,10,12). The role of the
basal cells is not yetfully defined. It has been suggested
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that basal cells do not serve asprecursor cells but solely
as support cellsforthe secretory orciliated cells. The des-
mosomal junctions between basal and columnar cells
would function as anchors for the columnar cells and
would be necessary fortheir attachment. Recent studies
usingisolatedbasal cells fromtherabbittracheahave in-
dicated thatthese cells are capable ofregenerating a nor-
mal, fully differentiated epithelium when inoculated into
denudedtracheastransplanted onthebackofnude mice
(11,13). These findings appear to suggest that the basal
cell has the capacity for self-renewal, as well as the abil-
ity to give rise to various differentiated cells, and there-
fore constitutes a stem cell in the tracheobronchial
epithelium.
Under a variety of conditions the tracheobronchial
epitheliumfollows apathway ofsquamous cell differenti-
ation. Vitamin A deficiency, toxic ormechanical injury in-
duce hyperplasia that is followed by squamous metapla-A. M. JETTEN
sia(14-27). Under these conditions, the pseudostratified
epithelium is replaced by a stratified squamous epi-
thelium. This alternate pathway of differentiation has
many morphological and biochemical properties in com-
mon with epidermal differentiation, although several
differences have been noted as well. The squamous path-
way ofdifferentiation can also be observed inmany squa-
mous cell carcinomas of the lung (28-30).
Several invitro culture systemsusingtracheobronchial
epithelial cells from different species have been developed
to gain insight into the mechanisms that regulate the
proliferation and differentiation ofthese cells (31-40). A
clearinsight into the basic mechanisms ofthese processes
is required in order to understand the mechanisms in-
volved in tumor development andotherpathological con-
ditions. This review is not aimed atgiving a detailed over-
view of the regulation of differentiation in various
tracheobronchial epithelial cells from various species but
focuses onthe regulation ofsquamous cell differentiation
in the rabbit tracheal and human tracheobronchial
epithelial cell systems. In addition, since squamous cell
differentiation in the tracheobronchial epithelium exhibits
many characteristics of epidermal differentiation, in
several instances a comparison is made with the differen-
tiation process of human epidermal cells.
Clonogenic Tracheobronchial
Epithelial Cells Are Pluripotent
Several in vitro culture systems of tracheobronchial
epithelial cells have been developed to study the regula-
tion of differentiation of these cells (31-40). Our labora-
tory has been concentrating on the epithelial cells from
the rabbit trachea as aninvitro model system(39,41-44).
These cells can be grown inprimary culture in a defined
medium consisting ofHam's F12 medium supplemented
with transferrin, epidermal growth factor (EGF), and in-
sulin. Although insulin is required for proliferation of
these cells, insulin growth factor 1 (IGF1), stimulates
growth at aconcentration that is 100-foldlowerthan that
of insulin, suggesting that both of these growth factors
operate via the IGF,-receptor.
Rabbit tracheal epithelial cells proliferate rapidly with
adoublingtime ofapproximately 19hr. These cells appear
morphologically and biochemically similar to tracheal
basal cells (A. M. Jetten, unpublished). Cells exhibit a
large nucleus to cytoplasm ratio and containperinuclear
tonofilaments. The keratinprofile ofthese cells is identi-
cal to that ofcultured cells derivedfrom a95% pure basal
cellpreparation and similar to that ofbasal cells in other
tissues such as the epidermis. Isolated, single colonies of
these clonogenic rabbit tracheal epithelial cells are able
to repopulate denuded tracheas transplanted onto the
backofnude micegivingrise to afully differentiated, nor-
mal tracheal epithelium (13). In vitro, these cells have
been showntobe able to differentiate into squamous cells
or into mucosecretory cells (43). These findings suggest
that the clonogenic cells in culture arepluripotent: They
have the capacity for self-renewal and are able to differen-
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FIGURE 1. Tentative pathway of differentiation of pluripotent
tracheobronchial epithelial cells. Clonogenic tracheobronchial
epithelial cells have the capacity for self-renewal and appear able to
differentiate along either squamous cell or mucosecretory pathways.
Themucosecretory cellretainsproliferative capacity andcan undergo
maturation into a Goblet cell or terminally differentiate into aciliated
cell. Morphological characteristics andthe expression ofkeratin pro-
teins suggest that the clonogenic cell may be closely related to the
basal cell.
tiate alongeither a mucociliary or a squamous cell path-
way. The morphological features and the keratin profile
expressedby these cells suggest that they are basal cells
or closely related to basal cells (Fig. 1).
Expression of the Squamous-
Differentiated Phenotype
Squamous differentiation in tracheobronchial epithelial
cells has many similarities to epidermal differentiation,
although several differences have beennotedbetween the
two cell systems. The expression of the squamous cell
phenotype by tracheobronchial and epidermal epithelial
cells in culture is characterized bymorphological andbio-
chemicalmarkers. Whenundergoing squamous differen-
tiation, cells obtain a squamous morphology, contain in-
creased tonofilaments, form increased number of
desmosomaljunctions, andexhibit a decreasednucleus to
cytosol ratio, which is related to increased cell size
(33,45-48).
At alater stage in this differentiation process, cells un-
dergo cornification (33,39,46,49-51), which is character-
ized by the formation of cross-linked envelopes, consist-
ing of a layer ofcross-linked protein, about 100 A thick,
depositedjustbeneath the plasmamembrane. Cornifica-
tion is accompanied by degradation of the cellular or-
ganelles. Severalfactors are involved in theformation of
the cross-linked envelope: protein precursors that form
the constituents of the envelope and transglutaminase
type I (epidermal transglutaminase), the enzyme that
catalyzes the covalent linkage between the precursors
(52-56). Involucrin(57,58) and a 190 kD protein(59) have
been identified and characterized as precursors of the
cross-linked envelope in human epidermal keratinocytes.
Involucrin has also been found in differentiating human
tracheobronchial epithelial cells (60,61). The involucrin
message hasbeenrecently clonedand sequenced(62). In
rabbit tracheal epithelial cells, a 36 kD protein has been
identified as a constituent of the cross-linked envelope
(Smits andJetten, unpublished). Intheepidermis, the in-
duction ofinvolucrin andtransglutaminase synthesis oc-
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curs when cells pass from the spinous to the granular
layer (53,58). In tracheas ofvitamin A-deficient hamsters,
the presence oftransglutaminase is associated with the
squamous and cornifying layers in metaplastic foci (46).
Recently, the accumulation of cholesterol sulfate has
been shown to be associated with squamous cell differen-
tiation in tracheobronchial andepidermal epithelial cells
in culture (63-65). Theincrease in cholesterol sulfate has
been related to an increase in the enzyme cholesterol
sulfotransferase (68). Although a function for the
cholesterol sulfate accumulation in the process of squa-
mous differentiation hasnotbeen established, ithasbeen
suggestedthatitmayplayarole inthemodulation oflipid
metabolism(67-69). Inthe epidermis, cholesterol sulfate
accumulation, like the induction oftransglutaminase type
I activity and involucrin synthesis (53,58,70,71), is asso-
ciatedwiththe transition ofthe cellsfromthe spinous to
the granular layer. In vitro as well as in vivo, the induc-
tion ofthese biochemical parametersprecedes the forma-
tion ofthe cross-linked envelope, indicatingthat still other
factors are involved inenvelopeformation. Itislikelythat
the synthesis or modulation of other precursors or in-
creasedCa2+ concentration, neededforthe activation of
transglutaminase, might be required (59,72).
The expression of keratin intermediate filament pro-
teins is dependent onthe cell type andthe differentiated
state of cells. The regulation of keratin expression in
epidermal andtracheobronchialepithelial cellsiscomplex.
Basal cells isolatedfromthe rabbittrachea express three
majorkeratins: keratins K5(58kD), K14(50kD), and K19
(40kD) (73). Keratins K5 and K4 are also the major kera-
tins in epidermal basal cells. Epidermal andtracheobron-
chial epithelial cells in culture express two additional ma-
jor keratins, keratins K6 (56 kD) and K16 (48 kD) (A. M.
Jetten etal., unpublished; 74-76). The expression ofker-
atins K6andK16appears tobe associatedwiththehyper-
proliferative state ofthese epithelial cells. Rabbit tracheal
epithelial cells in culture exhibit increased expression of
the keratins K6, K16, and K13 (46 kD) during squamous
cell differentiation (39; A. M. Jetten et al., unpublished).
Inthe skin, epidermal cellsundergo keratinization and
start to express keratins Ki and K2 (67 and 65 kD) and
K10 and Kll (56.5 and 56 kD) (74,77,78). However,
tracheobronchial epithelial cells undergoing squamous
differentiation in vivo or in vitro appear not to express
these keratins (61,79,80). Human epidernal keratinocytes
inmonolayer culture in serum-freemedium also do not ex-
press keratins Ki, K2, K10, and Kll during squamous
differentiation, indicatingthat these cells underthis con-
dition do notundergo complete differentiation. However,
cells canundergo complete differentiation whengrown in
the presence of3T3feeder cells or on acollagengelwhile
exposed to air(77,81). The induction oftransglutaminase
and cholesterol sulfate on one handandtheexpression of
keratins Ki, K2, K10, and Kll, as well as the synthesis
offilaggrin, appear to constitute two different, possibly
consecutive, steps in the differentiation process that are
regulated differently.
Ib studytheregulation ofgeneexpression during squa-
mous differentiation oftracheobronchial epithelial cells,
a cDNA library was constructed from cultured rabbit
tracheal epithelial cells that had undergone squamous
differentiation (82). Screening ofthe library was aimed at
identifying RNAs thatare abundant in squamous differ-
entiation cells and not expressed in undifferentiated,
proliferative cells. Two differentrecombinants, designated
SQ10 and SQ37, were obtainedthat hybridizetomRNAs
1.0 and 1.25 kb in length, respectively. These RNAs are
present at approximately 50-fold higher levels in squa-
mous cells thaninproliferative cells. The identity ofthese
gene products is not known, and work is in progress to
sequence the SQ10 and 37 inserts.
Commitment to Terminal Cell
Division
Coupling between Growth Control and
Regulation ofDifferentiation
Rabbittracheal epithelial cellsin monolayer culture un-
dergo squamous differentiation when reaching the con-
fluent phase ofthe growth curve (43). Recently, we have
proposed a multistep modelfor thisprogram ofdifferen-
tiation composed ofatleast three distinct stages: An ini-
tial step involving commitment to terminal cell division,
a second stage duringwhich differentiated characteristics
are expressed, and finally cornification (Fig. 2) (41-44).
This model not only applies to rabbit tracheal epithelial
cells but also to a large extent to monolayer cultures of
human tracheobronchial and epidermal cells grown in
serum-free media(33,64,83-85). The commitment to ter-
minal cell division is characterized by the irreversible
reduction in colony-forming efficiency (ability of cells to
form colonieswhen subcultured atlow density)and an ac-
cumulation of the cells in Go/G1 phase of the cell cycle
(43,85). The reduction in colony forming efficiency has
been proposed as a marker for the conversion of the
proliferative, undifferentiated cell to one committed to
terminal differentiation. Terminal cell division in rabbit
tracheal and human bronchial epithelial cells not only oc-
curs at confluence but can be induced in cultures during
the exponentialgrowthphase whencells are treatedwith
thephorbol esterphorbolmyristate acetate (PMA)(A. M.
Jetten, unpublished; 43,86,87) orwhenthegrowthfactors
EGF and insulin are removed from the medium. Con-
fluency, withdrawal ofgrowth factors, or the addition of
phorbol esters can also induce differentiation in epider-
mal cells (85,88-92).
In normal tracheobronchial and epidermal epithelial
cells, an inverse relationship exists between proliferation
and expression ofthe squamous differentiatedphenotype.
A state of irreversible growth arrest not only precedes
the expression ofthe squamous differentiatedphenotype
but appears to be an obligatory step before expression of
this differentiated phenotype can occur. Little is known
abouttheprocess ofterminal cell division orthe molecu-
lar mechanisms involved in the coupling ofthe controls of
growth and differentiation in these cells. It is likely that
specific changes in gene expression accompany the com-
mitment to terminal cell division. Activation of specific
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FIGURE 2. Multistep process ofsquamous cell differentiation in tracheobronchial and epidermal epithelial cells. During the exponential phase ofthe
growth curve cells are hyperproliferative. A confluence cells become irreversibly growth-arrested (terminal cell division) and start to express a
squamous differentiatedphenotype characterizedbysquamousmorphology, induction oftransglutaminase type I activity and accumulation ofcholes-
trol sulfate followed by cross-linked envelope formation. High Ca2+ concentration orretinoids (RA) donot effectterminal cell division butinfluence
the expression ofthe differentiated phenotype.
genes (suppressor or antiproliferative genes) that irre-
versibly block the proliferation of the cell might be in-
volved, as well as the suppression of genes whose func-
tion it is tomaintain theproliferative potential ofthe cells.
The mechanisms which underlie the induction of termi-
nal cell division during squamouscell differentiation may
be similar to those which operate to induce terminal cell
division during senescence. Recently, the existence of
abundant antiproliferative mRNAs has been demon-
strated in senescent human fibroblasts (93). Alterations
in the expression ofthe same orcloselyrelated genes may
be involved in both of these processes.
Action of Retinoids
As early as 60 years ago (15), retinoids were recogrnized
as modulators of differentiation in several epithelial tis-
sues including the tracheobronchial epithelium and the
epidermis (94,95). Studies withwhole animalsand invivo
organ culture models showed that during vitamin A defi-
ciency the tracheobronchial epithelium undergoes exten-
sive squamous metaplasia (14-16,20,23,24). This process
is reversible: after treatment with retinoids the normal
mucociliary epithelium is restored (12,23). In other
epithelial tissues aswell, retinoids have been shown to in-
hibit squamous differentiation (94,95). Several in vitro cell
culture systems havebeenused to study the action ofreti-
noids on squamous differentiation (43,96-98). In the mul-
tistep program of squamous cell differentiation proposed
in Figure 2 retinoids affect very specific stages of squa-
mous differentiation whereas other stages are insensitive
to retinoids. Retinoids do not block the commitment to
terminal cell division in tracheobronchial or epidermal
cells inducedby confluence, withdrawal ofEGF andinsu-
lin or addition ofTGF-P or PMA (43,64,73); however, reti-
noids do blockthe expression ofthe differentiatedpheno-
type. Retinoids inhibit the induction oftransglutaminase
type I (54,99-102) and cholesterol sulfotransferase activ-
ities, inhibit the accumulation of cholesterol sulfate
(63-66), and inhibit cornification in several in vitro tra-
cheobronchial and epidermal cell systems (39,43,103-105).
In addition, retinoids markedly alter keratin expression
in these cells. In epidermal keratinocytes, retinoids inhibit
the expression ofthe 67-65 kD (Kl and K2) and 56, 56.5
(K1O and Kll) kD keratins, which are markers for ker-
atinization (77,106).
In tracheobronchial and epidermal cells, retinoids in-
hibit the synthesis ofkeratins K5(58kD), K6(56kD), and
K16(48 kD)andincrease the synthesis ofkeratin K19 (40
kD) (75,80,107). In rabbit tracheal epithelial cells, retinoic
acid also inhibits the increase in two squamous cell
specific mRNAs, SQ10 and SQ37(82). The differential ef-
fect ofretinoids on the commitment to terminal cell divi-
sion and expression ofthe differentiated phenotype sug-
gest that these two processes are controlled separately.
However, as stated earlier, regulation of these two pro-
cesses appears to be linked.
At what level retinoids control the expression of the
differentiated phenotype remains to be established. The
effects ofretinoids on keratin expression is related to al-
terations inthe levels ofcorrespondingmRNAs(106,107).
Also the inhibition ofthe expression ofSQ10 and SQ37 is
related to changes in their mRNA levels (82). Retinoids
may act at many levels, affecting gene expression at the
transcriptional level aswell as affectingthe transport or
stability of certain mRNAs. Chytil and Ong (108) have
proposed that retinoids act like steroid hormones via
specificreceptors thatinteractwith specific sequencesin
the chromatin, therebyalteringgenetranscription. Chytil
and Ong (108,1091) and later many other investigations
(95,110,111) haveidentified specific cytosolicbindingpro-
teinsforretinoic acid andretinol, designated CRABP and
CRBP,respectively, inmanytissuesandcelllines. For em-
bryonal carcinoma cells, mutant cell lines have been iso-
lated that do not respond to retinoic acid and lack
CRABP, suggesting arole forCRABPinthemechanism
of action ofretinoids (112,113).
However, in many cell lines that dorespondto retinoids,
such as in promyelocytic leukemia HL60 cells (111,114),
no detectable levels of CRABP have been found. In ad-
dition, certainbenzoic acidderivatives ofretinoicacid(Ch-
series)whichare equallyormore activethanretinoicacid,
are unable to bind to CRABP (100). These studies indi-
cate that CRABP may not be essential for the action of
retinoids andthat otherreceptors may be involved inthe
mechanism of action. Recently, a human retinoic acid
receptor(RAR)hasbeenidentifiedthatbelongs to afam-
ilyofnuclearreceptors(115,116). Thisreceptorprotein is
homologoustothereceptorsforsteroidhonnones, thyroid
hormones, and vitamin D3 and appears to be a retinoic
acid-inducible, trans-acting enhancer factor. This recep-
tor has a high affinity for retinoic acid and at least a
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100-fold lower affinity for retinol (115) and is present in
low abundance (several thousandmolecules/cell). Itisnot
known whether a similar nuclear receptor exists for
retinol. It is possible that the action of the Ch-series of
retinoids is explained by the binding ofthese analogs to
the RAR protein.
Whether CRABP and RAR cooperate in the mecha-
nism ofaction ofretinoids remains to be investigated. In
Figure 3, two possible mechanisms of action are illus-
trated thatmightbe involved inthe regulation ofdifferen-
tiation by retinoids. Figure 3A shows a model in which
CRABP translocates retinoic acidto the nucleus andthen
transfers the retinoic acid to the nuclear receptor. Such
a model would explain the absence ofresponsiveness in
embryonal carcinoma cells lacking CRABP activity
(112,113) if CRABP is essential for retinoic acid action.
The latter, however, would not be in agreement withfind-
ings showingthat in certain cell systems, cellsrespond to
retinoic acid in the absence ofCRABP(114,115). The ac-
tivity ofthe retinoic acid analogs ofthe Ch-series, which
do not bind to CRABP, also indicate that CRABP is not
essential forthe action ofretinoids. Itispossible that the
analogs ofthe Ch-seriesbypass CRABP andbind directly
to RAR. Inthe secondmodel(Fig. 3B), CRABPis notin-
volved in the mechanism ofactionandretinoic acidbinds
to RAR directly. The cellular localization of RAR is not
known; possibly all the RAR is associated with the nu-
cleus. Alternatively, RAR is localized in the cytosol and
afterbindingretinoic acid is translocated to the nucleus.
This model would not explain why in mutant embryonal
carcinomacelllinesthat lackCRABP, cells do notrespond
to retinoic acid. Future studies will be needed to deter-
mine whatrole CRABPplays inthe mechanism ofaction
of retinoids.
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During differentiation, cells undergo a complex pro-
gram of changes in gene expression. Interaction of the
RAR-RA complexwith specific enhancersequences could
activate orrepress thetranscription ofspecificgenes as-
sociated with the differentiated phenotype in
tracheobronchial and epidermal cells (Fig. 4). Some of
thesegenes mightrepresenttranscriptional factorswhich
thenregulate the transcription ofothergenes whose ex-
pression is associated with the differentiated phenotype
such as genes for keratins, transglutaminase type I, and
sulfotransferase. Changesinthe activity ofspecific tran-
scriptional factors have been demonstrated during
retinoic acid-induced differentiation of embryonal carci-
noma cells (117-118). The transcription of such factors
mightbe under direct controlby RA-RAR anddetermine
the expression ofmany other genes during the differen-
tiationprocess(Fig. 4). It seems certainthatthe activity
ofspecific transcriptional factors will be shown to play a
key role in regulating the complex changes in gene ex-
pression that occur during differentiation.
Role of Calcium
Calciumions caninfluence various aspects ofsquamous
cell differentiation in tracheobronchial epithelial and
epidermal cells. In murine epidermal keratinocytes, a cal-
cium concentration of > 100 lM in the medium induces
terminal differentiation (119-121). In contrast, tracheo-
bronchial epithelial andhuman epidermal cells exhibit op-
timal growth at calcium concentrations > 100 ,4M
(33,43,84,85) and maintain a high colony-forming effi-
ciency. However, high calcium does induce a reversible
morphological change inthese cells(33,43,84,85): cells es-
Nucleus DNA I
Nucleus
altered gene
expression
DNA
AR -
*RA-RAR *- e p
FIGURE 3. Mechanisms ofaction ofretinoic acid. (A) Cooperative model. Retinoic acid(RA)binds to the cytosolic retinoic acidbindingprotein(CRABP)
andis translocated to the nucleus where retinoic acid istransferred to the nuclearretinoic acid receptor(RAR). This complex interacts with specific
enhancer sequences modulatingthetranscriptional activity ofcertaingenes. (B) Noncooperative model. The CRABPis not involved in the mech-
anism ofaction ofretinoic acid. Retinoic acidinteracts directly with RAR in the cytosol ornucleus. The RA-RAR complexinteracts subsequently
with chromatin thereby altering gene expression.
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FIGURE 4. Direct and indirect modulation ofdifferentiation markers by retinoic acid. Regulation ofgene expression by retinoic acid can occur in a
direct orindirect manner. Retinoic acid-nuclearretinoic acidreceptor (RA-RAR) complex interaction with specific enhancer sequences could acti-
vate or repress the transcription ofspecificgenes (direct control) associated with the differentiated phenotype such as genes for mucin, keratins,
transglutaminase type I and sulfotransferase. Some ofthese genes might represent transcriptional factors which then regulate the expression of
other genes (indirect control).
tablish cell-cell contacts and desmosomaljunctions (119).
High calcium alone does notinduce terminal cell division
in proliferating tracheobronchial or human epidermal
cells; however, when cells undergo terminal cell division
at confluence, high calcium concentrations stimulate the
expression of the squamous differentiated phenotype
(43,63,64,96,102). High calcium concentrations increase
transglutaminase type I activity andthe accumulation of
cholesterol sulfate and increase the rate of cross-linked
envelope formation inboth tracheobronchial and epider-
mal cells. The mechanism by which calcium modulates
differentiation is still poorly understood.
Transforming Growth Factor (
Transforminggrowth factorp(TGF-p) is apolypeptide
hormone that is expressed andreleased bymanynormal
and neoplastic cells (123,124). It consists of two 12 kD
chainslinkedby disulfide bondsandis synthesized aspart
ofalarger secretory precursor(123). The total amino acid
sequences of human and mouse GIF-p are known from
their complementary cDNA and show a remarkable ho-
mology(125). TGF-Pis amultifunctional peptide that con-
trols cell proliferation, differentiation and other functions
in many cells types (126-130). The cellular responses to
TGF-P are mediated by specific cell-surface receptors
(131,132); however, little is known about the signal trans-
duction mechanism ofthe action of TGF-P.
The effect ofTGF-P on tracheobronchial epithelial cells
appears to depend on the cell density ofthe cultures. At
low density TGF-p induces terminal cell division, and in
thepresence ofhigh calciuminthe medium cells startto
express a squamous differentiated phenotype (133,134).
At high densities cells become much more resistant to
TGF-(3; whether this is due to cell-cell interaction or the
release ofan endogeneous factor into the medium is not
known. TGF-1 is synthesized by tracheobronchial
epithelial cells asitsprecursor. Thisfactormightplay an
important role in maintaining the balance between
proliferation and differentiation in the tracheobronchial
epithelium.
Phorbol Esters
Phorbol esters elicit a diverse set of responses in
tracheobronchial and epidermal cells. In epidermal cells
in culture, as well as in vivo, the different responses are
related to different subpopulations of undifferentiated
cells (basal cells) (135-138). In one subpopulation (popu-
lation A)(Fig. 5)phorbol esters induce aproliferative re-
sponse as indicated by a stimulation in 3H-thymidine in-
corporation and induction of ornithine decarboxylase
activity. In the other subpopulation (population B) (Fig.
5)phorbol esters induceterminal cell divisionand expres-
sion ofthe differentiated phenotype as indicated by the
induction oftransglutaminase type I activity, accumula-
tion ofcholesterol sulfate, andincreasedcross-linked enve-
lope formation (88-91,99).
PopulationAappears to consistofthe smallest cellsthat
have the lowest probability to undergo differentiation.
CellsfrompopulationA are believed togive rise to popu-
lation B cells, aprocess that is probably reversible (139).
Cultures ofhuman foreskin keratinocytes maintained in
serum-freemediumandinthe absence offeederlayersap-
pear to consist ofmostlypopulation B cells, as treatment
withphorbol esters does not induced ornithine decarbox-
ylase activity but does induce terminal differentiation in
most ofthe cells (89-91). However, when these cells are
cultured onfeederlayers, a subpopulation oftype A cells
is maintained (140-142). Tracheobronchial epithelial cells
inmonolayerculture appearlargely to behave like popu-
lation B cells (64,86,87,143). After treatment with phor-
bol esters, cells undergo terminal cell division and start
to express type I transglutaminase activity, accumulate
cholesterol sulfate, andfonn cross-linked envelopes (A. M.
Jetten, unpublished; 64). Whether tracheobronchial
epithelial cells at one point after isolation contain popu-
lation A cells is not known.
Cultures ofhuman bronchial epithelial cells have been
shown to respond heterogeneously to the phorbol ester
PMA(143). Infreshlyisolatedrattrachealepithelial cells,
PMAincreases the colonyformingefficiency, whereas in
primary culturesPMAinducesterminal differentiation in
all cells(144). These studies indicate adiversity inthe re-
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FIGURE 5. Schematic view ofthe mechanisms by which the phorbol ester PMA, bryostatin, and retinoic acid modulate squamous cell differentia-
tion intracheobronchial andepidermal epithelial cells. In cell subpopulation A, PMAinduces cell proliferation as indicatedby increased ornithine
decarboxylase activity(ODC) and 3H-thymidine incorporation. Subpopulation A cells can convertreversibly into subpopulation Bcells, which re-
spond to PMA by undergoing terminal differentiation. Bryostatin mimics the effect of PMA in subpopulation A cells. In subpopulation B cells,
bryostatin antagonizes the induction ofsquamous cell differentiation by PMA. Bryostatin blocks both the induction ofterminal cell division as
well as the expression ofthe differentiated phenotype. Retinoic acid does not influence the commitment to terminal cell division but does inhibit
the expression ofthe differentiated phenotype.
sponse of tracheobronchial epithelial cells to PMA that
perhaps is related to different subpopulations ofundiffer-
entiated cells similartopopulation Aand B cells. Itisnot
known what molecular changes dictate the different
responses ofpopulation A and B cells to phorbol esters.
The major action ofphorbol esters in cells is mediated
bythe activation ofproteinkinase C, whichisencodedby
afamily ofclosely related genes (145). Diacylglycerol, the
endogeneous activatorofproteinkinaseC,producesmany
of the same effects reported for phorbol esters (146).
Bryostatins, macrocyclic lactones isolated from marine
bryozoan Bugulaneritina(174), bind to and activate pro-
tein kinase C (148-152). Like phorbol esters, they can in-
duce ornithine decarboxylase activity and 3H-thymidine
incorporation in subpopulation A mouse epidermal cells
(152). However, bryostatin does not induce terminal
differentiation in subpopulation B mouse epidermal cells,
as phorbol esters do (152).
In contrast, bryostatin inhibits terminal differentiation
induced by the phorbol ester PMA(152). In both human
epidermal keratinocytes and tracheobronchial epithelial
cells, bryostatin also inhibits squamous cell differentiation
induced by PMA (A. M. Jetten, unpublished). Bryostatin
inhibits boththe commitment to terminal cell division in-
duced by PMA as well as the expression ofthe differen-
tiated phenotype (A. M. Jetten, unpublished). The mech-
anism ofthis antagonismispoorlyunderstood. Epidermal
and tracheobronchial epithelial cells could express several
protein kinase C isoenzymes that could be affected by
phorbol esters andbryostatins in differentways interms
of affinity, downregulation, or substrate specificity
(149-152). Alternatively, bryostatin could act via more
than one mechanism: one action ismediated via the acti-
vation ofprotein kinase C that is antagonized by the ac-
tivation ofa yet unknown pathway unrelated to protein
kinase C.
Retinoic acid has a quite different effect on the process
ofterminal differentiationinducedbyphorbol estersthan
bryostatins. Although retinoic acid does not inhibit the
commitment to terminal cell division induced byphorbol
esters in eitherepidermal or tracheobronchial epithelial
cells(A. M. Jetten, unpublished), itdoesinhibittheinduc-
tion by PMA oftransglutaminase type I activity, the ac-
cumulation of cholesterol sulfate and cross-linked enve-
lope (99; A. M. Jetten, unpublished). These findings
suggest thatretinoic acidinhibitsexpression ofthe squa-
mous differentiated phenotype. Studies in mouse epider-
mal cellshave shownthatretinoicacidcan alsoinhibitthe
induction ofornithine decarboxylase activityby PMA in
population A cells (153). These results indicate that
retinoic acid can act at more than one stage in the
differentiation process.
Figure 5 shows a schematicreviewofthe action ofphor-
bol esters, bryostatin, andretinoic acid on theprocess of
squamous cell differentiation in epidermal and
tracheobronchial epithelial cells. Phorbol esters induce
terminal cell divisioninpopulation B cellsfollowedby ex-
pression of the differentiated phenotype. Bryostatin
blocks the first stage in this differentiation process
whereas retinoic acid blocks the second stage.
Hyperplasia, Squamous Metaplasia
and Squamous Cell Carcinomas
In the normal pseudostratified tracheobronchial epithe-
lium, a strict balance existsbetween cellularproliferation
and differentiation. This balance is likely maintained via
an equilibrium between positive and negative growth
regulatoryfactors andfactors controlling differentiation.
Studies in vitro have shown that proliferation of
tracheobronchial cells is dependent on EGF/TGF-a and
insulinlike growth factors and is regulated in a negative
manner by TGF-p (34,39,133,134). Otherfactors, such as
interferons and interleukins, may also regulate prolifer-
ation in these cells. It is likely that these positive and
negative regulatory factors also play a role in maintain-
ingabalance betweenproliferation and differentiation in
vivo.
Cells in the normal tracheobronchial epithelium have a
lowmitoticrate, ashasbeenestablishedforthebasal cells
in the skin. Many cells are withdrawnfromthe cell cycle
and remain in the resting (Go) phase. During vitamin A
deficiency or aftermechanical ortoxicinjury, the balance
between proliferation and differentiation is disturbed; the
epithelium undergoes hyperplasiafollowed by squamous
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metaplasia (14-27).
In the case ofmechanical and toxic injury this process
may be part of a wound healing or tissue repair mecha-
nism. The mechanism underlying the hyperplastic re-
sponse has not been completely elucidated. Hyperplasia
may involve recruitment of the cells in the Go-compart-
mentandre-entry ofthese cells into the cell cycle Altered
synthesis or activation of specific positive or negative
growth regulators may induce the Go to GI transition in
resting cells and initiate their proliferation. Studies car-
ried out by Stahlman et al. (154,155) are in agreement
with this concept. Increasedlevels ofEGF, administered
IV to fetal lambs, induces hyperplasia and squamous
metaplasia in the tracheobronchial epithelium.
The fact that thephase ofhyperproliferation (hyperpla-
sia) is followed by a phase in which cells stop proliferat-
ing and undergo squamous differentiation (squamous
metaplasia) indicates that cellularproliferation is not un-
limited but strictly controlled. However, the molecular
mechanisms that trigger terminal differentiation invivo
have not yet been established. Increased synthesis or ac-
tivation ofTGF-p, which can induce terminal differentia-
tion oftracheobronchial cells in vitro (133,134), may also
be involved in the induction ofsquamous differentiation
in vivo.
Thelung, inparticular thebronchial epithelium, is ama-
jor site for tumor formation in humans. Environmental
factors, such as cigarette smoke, in conjunction with
genetic (hereditary) factors are important determinants
in this disease. Itisbelievedthatthe acquisition ofdefects
in the control ofproliferation and differentiation are im-
portant steps in the multistage process ofcarcinogenesis.
Alterations in the mechanisms that control hyperplasia
and squamous metaplasia are thought to be involved in
the development ofsquamous cell carcinomas. Activation
ofspecific protooncogenes, constitutive synthesis ofpoly-
peptidegrowthfactors, decreasedresponsiveness tonega-
tivegrowthregulators, aswell as theloss ofantiprolifer-
ative or tumor suppressor genes are believed to be the
molecular mechanisms involved in the conversion ofanor-
mal cellinto atransformed cell. Forexample, tracheobron-
chial epithelial cells expressingthe SV40-large T-antigen
have an indefinite life span and are resistant to certain in-
ducers ofdifferentiation (A. M. Jetten, unpublished); ac-
tivatedoncogenesfromtheras, myc, andraffamilies have
beenfound associated withlungcarcinomas, andlung car-
cinoma celllines have beenfound to be much more resis-
tant to the growth-inhibitory effects ofTGF-p than nor-
mal tracheobronchial epithelial cells (133,134). Such
alterations in gene activity reduce the ability ofa cell to
become quiescent and arrestedin theGo, reduce itsprob-
ability to undergo terminal differentiation, and promote
uncontrolled proliferation.
Summary
Itis clearthat the use ofinvitro cell systems hasbeen
very useful in identifying not only various factors that
control proliferation and differentiation in tracheobron-
chial epithelial cells but also several biochemical and
molecular markers that are associated with the expres-
sion of the differentiated phenotype. Studies have indi-
cated that the program of squamous differentiation is a
multistep process. Elucidation ofthe mechanism ofaction
of these regulatory factors and the mechanism of gene
regulation are required to understand the process by
which differentiation is controlled. Introduction oftrans-
forminggenes in normal tracheobronchial cells, yielding
cells nonresponsive to differentiation inducers, appearto
be apromising approach that mayprovide insight in the
process of carcinogenesis.
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